U.S. Markets closed

EVIO, Inc. (EVIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0068-0.0014 (-17.07%)
At close: 3:59PM EST

EVIO, Inc.

2340 West Horizon Ridge Parkway
Suite 120
Henderson, NV 89052
United States
541 633 4568
http://eviolabs.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees43

Key Executives

NameTitlePayExercisedYear Born
Ms. Lori Jean GlauserPres, COO, Interim CEO & Interim Chair of the Board117kN/A1969
Mr. William H. WaldropConsultant144.09kN/A1969
Cheryl KrampDirector of MarketingN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

EVIO, Inc., together with its subsidiaries, provides analytical testing and advisory services to cannabis industry in the United States. The company's consulting services include advisory, product formulation, and licensing and compliance services. It also offers various testing services comprise cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, biological contaminant testing, and other services. EVIO, Inc. is headquartered in Henderson, Nevada.

Corporate Governance

EVIO, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.